1. AHRO : Austin Health Research Online

Louise M Burrell

View Statistics Email Alert RSS Feed
 Claim profile

Profile

Loading... 2 0 20 0 false
Credit Name
Louise M Burrell
Full Name
Burrell, Louise M
 
Title
Prof
 
Department
 
ORCID
Twitter
Loading... 3 0 20 0 false

Publications

Refined By:
Subject:  Blood Pressure.drug effects

Results 1-16 of 16 (Search time: 0.012 seconds).

Publication YearTitleAuthor(s)
11-Jun-2014More rigorous protocol adherence to intensive structured management improves blood pressure control in primary care: results from the Valsartan Intensified Primary carE Reduction of Blood Pressure study.Stewart, Simon; Stocks, Nigel P; Burrell, Louise M ; de Looze, Ferdinandus J; Esterman, Adrian; Harris, Mark; Hung, Joseph; Swemmer, Carla H; Kurstjens, Nicol P; Jennings, Garry L; Carrington, Melinda J
218-Oct-2012Angiotensin-(1-7) reduces the perfusion pressure response to angiotensin II and methoxamine via an endothelial nitric oxide-mediated pathway in cirrhotic rat liver.Herath, Chandana B; Mak, Kai; Burrell, Louise M ; Angus, Peter W 
31-Jun-2003Upregulation of cardiac insulin-like growth factor-I receptor by ACE inhibition after myocardial infarction: potential role in remodeling.Dean, Rachael G; Bach, Leon A; Burrell, Louise M 
41-Apr-2002Neurohormonal antagonism in heart failure; beneficial effects of vasopressin V(1a) and V(2) receptor blockade and ACE inhibition.Naitoh, Mareo; Risvanis, John; Balding, Leanne C; Johnston, Colin I; Burrell, Louise M 
51-Apr-2002Combined inhibition of neutral endopeptidase with angiotensin converting enzyme or endothelin converting enzyme in experimental diabetes.Tikkanen, Ilkka; Tikkanen, Tuula; Cao, Zemin; Allen, Terri J; Davis, Belinda J; Lassila, Markus; Casley, David J; Johnston, Colin I; Burrell, Louise M ; Cooper, Mark E
61-Aug-2001Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomized rats.Cao, Zemin; Burrell, Louise M ; Tikkanen, Ilkka; Bonnet, Fabrice; Cooper, Mark E; Gilbert, Richard E
71-Dec-2000Beneficial renal and cardiac effects of vasopeptidase inhibition with S21402 in heart failure.Burrell, Louise M ; Farina, N K; Balding, Leanne C; Johnston, Colin I
81-Oct-2000Antihypertensive and antihypertrophic effects of omapatrilat in SHR.Burrell, Louise M ; Droogh, J; Man in't Veld, O; Rockell, M D; Farina, N K; Johnston, Colin I
91-Jun-2000Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs.Farina, N K; Johnston, Colin I; Burrell, Louise M 
1017-Sep-1999In vivo and in vitro characterisation of a nonpeptide vasopressin V(1A) and V(2) receptor antagonist (YM087) in the rat.Risvanis, John; Naitoh, M; Johnston, Colin I; Burrell, Louise M 
111-Oct-1998Dual inhibition of neutral endopeptidase and angiotensin-converting enzyme in rats with hypertension and diabetes mellitus.Tikkanen, T; Tikkanen, Ilkka; Rockell, M D; Allen, Terri J; Johnston, Colin I; Cooper, Mark E; Burrell, Louise M 
121-Jul-1998Long-term effects of nonpeptide vasopressin V2 antagonist OPC-31260 in heart failure in the rat.Burrell, Louise M ; Phillips, P A; Risvanis, John; Chan, Robert K ; Aldred, K L; Johnston, Colin I
1316-May-1998Effects of chronic AVP V2R blockade in congestive heart failure in sheep. Comparison with chronic ACE inhibition.Naitoh, M; Power, JM; Phillips, P A; Risvanis, John; Johnston, Colin I; Burrell, Louise M 
148-Jul-1997Chronic vasopressin antagonism in two-kidney, one-clip renovascular hypertension.Burrell, Louise M ; Risvanis, John; Phillips, P A; Naitoh, M; Johnston, Colin I
151-Feb-1997Modulation of genetic hypertension by short-term AVP V1A or V2 receptor antagonism in young SHR.Naitoh, M; Burrell, Louise M ; Risvanis, John; Aldred, K L; Rockell, M D; Johnston, Colin I; Phillips, P A
161-Jun-1994Blood pressure-lowering effect of an orally active vasopressin V1 receptor antagonist in mineralocorticoid hypertension in the rat.Burrell, Louise M ; Phillips, P A; Stephenson, J M; Risvanis, John; Rolls, K A; Johnston, Colin I